For citations:
Sultanbaev A.V., Tuzankina I.A., Kolyadina I.V., Nasretdinov A.F., Musin S.I., Sultanbaeva N.I., Menshikov K.V., Izmailov A.A., Sultanbaev M.V., Kudlay D.A. Efficiency of combined endocrine therapy with CDK4/6 inhibitors in metastatic HR+/HER2breast cancer: Immunological aspects. Medical Immunology (Russia). 2025;27(4):749-760. (In Russ.) https://doi.org/10.15789/1563-0625-EOC-3199